EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
3.650
-0.070 (-1.88%)
At close: Sep 24, 2026, 4:00 PM EDT
3.669
+0.019 (0.53%)
After-hours: Sep 24, 2026, 7:55 PM EDT
EyePoint Employees
EyePoint had 214 employees as of December 31, 2025. The number of employees increased by 49 or 29.70% compared to the previous year.
Employees
214
Change (1Y)
49
Growth (1Y)
29.70%
Revenue / Employee
$13,028
Profits / Employee
-$1,432,911
Market Cap
314.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 214 | 49 | 29.70% | 214 | 0 |
| Dec 31, 2024 | 165 | 44 | 36.36% | 165 | 0 |
| Dec 31, 2023 | 121 | -23 | -15.97% | 121 | 0 |
| Dec 31, 2022 | 144 | 21 | 17.07% | 144 | 0 |
| Dec 31, 2021 | 123 | 22 | 21.78% | 122 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Abeona Therapeutics | 226 |
| Rocket Pharmaceuticals | 202 |
| Enanta Pharmaceuticals | 120 |
| Ocugen | 116 |
| BridgeBio Oncology Therapeutics | 88 |
| SAB Biotherapeutics | 86 |
| Century Therapeutics | 78 |
EYPT News
- 3 days ago - These beaten-down stocks could bounce back in January, if history is any guide - Market Watch
- 8 days ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - EyePoint Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 14 days ago - EyePoint Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 15 days ago - EyePoint Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 15 days ago - EyePoint Slides: Corporate presentation - Filings
- 22 days ago - EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting - GlobeNewsWire
- 22 days ago - EyePoint downgraded to Hold from Buy at TD Cowen - TheFly